Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. CT ORDER Other Confidential Order
  2. 10-Q Report Quarterly Report
  3. S-3 Offering Registration Statement
  4. 8-K Event Material agreement
  5. 8-K Event Material agreement
  6. 4 Grant or award Director acquired 1,964 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 7,858 shares (grant or award)
  10. 4 Grant or award Director acquired 7,858 shares (grant or award)
  11. 8-K Event Material agreement
  12. 8-K Event Material agreement
  13. 8-K Event Shareholder vote results · Other events
  14. ARS Other Annual Report to Security Holders
  15. 10-Q Report Quarterly Report
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. DEF 14A Proxy Proxy Statement
  18. 4 Open-market sale Sr. VP, Drug Development sold 20,000 shares at an average $5.80 ($116,000)
  19. 8-K Event Material agreement
  20. SC 13D/A Stake Beneficial Ownership Report

Page 49 of 62 · 1,224 filings